The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines in vitro and in vivo is a research paper published in Frontiers in Microbiology (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: P01CA100730
NIGMS NIH HHS
Grant: T32 GM141955
National Institutes of Health
Grant: 5P01CA100730-05
Retrovirus Models of Lymphocyte Transformation/Disease
National Institutes of Health
Grant: 5T32GM141955-04
Cellular, molecular, and biochemical sciences training grant
FWCI
1.18
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals